MNPs in Human Body

The historical view of plastics as physically inert materials has been thoroughly disproved by clinical and toxicological research. Once discarded plastics break down in the environment through mechanical wear, photo-oxidation, and biological decomposition, they fragment into microplastics (MPs, 1 µm to 5 mm) and nanoplastics (NPs, <1 µm). At the nanoscale, these particles cease to be mere physical contaminants; instead, they function as active chemical vectors and interfacial structures that infiltrate Earth’s systems and bioaccumulate widely within the human body. Human biomonitoring has confirmed the presence of synthetic polymer particles across numerous biological matrices, including blood, stool, urine, feces, sputum, breast milk, and saliva.



Routes of Exposure and Barrier Translocation

Humans are chronically exposed to micro- and nanoplastics (MNPs) daily through three primary pathways:

  • Ingestion: The primary route of exposure. MNPs enter via contaminated food (e.g., seafood, table salt, agricultural crops) and beverages, especially from single-use plastic bottles, heated plastic take-out containers, or plastic teabags steeped in hot water.

  • Inhalation: Prominent in urban and indoor environments. Airborne plastic fibers and fragments—shed from synthetic textiles, tire wear, and atmospheric deposition—are inhaled into the lungs, where they can settle deep in the alveoli.

  • Dermal Contact: While less common, particles smaller than 40 nm can bypass outer dermal barriers, particularly through micro-abrasions or hair follicles during close contact with plastic-containing personal care products.

Once internalized, nanoplastics possess high biological permeability due to their large specific surface area. Because of their sub-cellular dimensions, they readily cross highly selective physiological barriers, including the intestinal barrier, pulmonary barrier, blood-brain barrier (BBB), and placental barrier.



Internalized Organ Pathology and Clinical Findings

As these particles disseminate through the circulatory and lymphatic systems, they accumulate in vital organs, triggering site-specific clinical pathologies.

1. Central Nervous System & Brain

The human blood-brain barrier cannot effectively block nanoscale plastic particles, enabling rapid accumulation in neural tissue. A landmark post-mortem analysis of human brain samples found an average of 4,917 micrograms of plastic per gram of brain tissue. In middle-aged individuals, this bioaccumulation means roughly 0.5% of the brain’s mass consists of plastic—equivalent to about 7 grams or a full plastic teaspoon inside the head.

Furthermore, brain samples from 2024 carried approximately 50% more plastic than those sampled in 2016, showing a steep upward trajectory in human exposure. This bioaccumulation is significantly more pronounced in patients with dementia or Alzheimer's disease than in healthy controls, suggesting a link to neurodegenerative disorders. Clinically, higher regional exposures have also been associated with notable increases in cognitive and mobility disabilities.

2. Cardiovascular System & Arterial Plaque

The clinical impact of plastics circulating in the bloodstream is strongly illustrated by cardiovascular pathologies. A major multicenter cohort study published in the New England Journal of Medicine (Marfella et al., 2024) analyzed excised carotid plaque specimens from patients undergoing endarterectomy. The researchers detected polyethylene (PE) in 58.4% of plaques (averaging 21.7 µg/mg of plaque) and polyvinyl chloride (PVC) in 12.1% (averaging 5.2 µg/mg of plaque).

Patients with detectable MNPs in their plaques had a 4.53-times higher risk of experiencing a myocardial infarction (heart attack), stroke, or death over a 34-month follow-up compared to patients without plaque-bound plastics. High plastic accumulation is also strongly associated with symptomatic carotid artery disease.

3. Gastrointestinal Tract

Ingested MNPs disrupt the mucosal barrier by damaging epithelial cells and weakening the tight junctions that maintain barrier integrity, causing a "leaky gut" state. This disruption permits particles and leached chemical additives to translocate across the epithelium into systemic circulation and the lymphatic system. The resulting chronic mucosal irritation, oxidative stress, and gut dysbiosis (microbiota imbalance) are recognized as modifiable risk factors for colorectal and esophageal cancers. Tissues with active pathological conditions (like inflamed intestines) exhibit significantly higher MNP accumulation than healthy tissues.

4. Reproductive Health

Universally detected in human male reproductive systems, mass-based analyses identified polymer particles—predominantly polyethylene—in 100% of archived human testes, as well as multiple polymers in semen samples. Nanoplastics compromise the blood-testis barrier (BTB) by downregulating tight junction proteins, specifically occludin and claudin-11. This allows particles to infiltrate seminiferous tubules, causing damage to Sertoli and Leydig cells, triggering testosterone deficiency, and impairing spermatogenesis. In females, microplastics have been found in the human placenta and in the ovarian follicular fluid of 14 out of 18 women examined, indicating that MNPs interfere with the earliest stages of life even prior to conception.



Primary Biophysical and Toxicological Mechanisms

Nanoplastics exert toxicity through distinct physical and chemical mechanisms:

  • The Macromolecular Corona: Upon entering biological fluids, nanoplastics’ high surface free energy drives the immediate adsorption of lipids, proteins, and cholesterol. This molecular cloaking masks the particles, giving them a "biological identity" that deceives the immune system and allows them to be internalized more readily by cells.

  • The "Trojan Horse" Vector Mechanism: Because of their physical properties, nanoplastics act as "chemical sponges" that concentrate hydrophobic co-contaminants—such as heavy metals, endocrine-disrupting chemicals (EDCs), phthalates, and polycyclic aromatic hydrocarbons (PAHs)—at concentrations far higher than those in the surrounding environment. Once cells internalize these particle-pollutant complexes, they are trafficked to acidic lysosomes. The sudden pH drop in lysosomes alters interfacial binding affinities, opening the "Trojan Horse" to release the concentrated toxic payload directly into the cytosol, inducing severe DNA damage, oxidative stress, and cell death.

  • Mitochondrial & Electrostatic Disruption: Electrostatically charged nanoplastics interact directly with negatively charged cellular components, destabilizing cell membranes and penetrating organelles. Inside cells, they directly target the mitochondria. This induces mitochondrial dysfunction, disrupting cellular energy production (ATP), altering intracellular signaling, and triggering programmed cell death (apoptosis).

  • Systemic Excretion Limitations: A critical toxicokinetic finding reveals that systemic excretion of nanoplastics is exclusively fecal, with 0% renal clearance. Because the kidneys cannot filter these nanoscale particles, they remain in biological systems for prolonged residence times, escalating the risk of chronic, irreversible damage.

The overall picture is outstandingly clear: micro- and nanoplastics are no longer just environmental contaminants, but highly pervasive, toxicologically active internal hazards embedded inside the human body.

1. Primary Exposure, Pathological, and Laboratory Studies

2. Clinical Findings, Media, and Consumer Guides

3. Planetary Health, Climate, and Treaty Regulations

0 comments

Leave a comment